Decentralized Clinical Trials (DCTs)

Take your trials to patients' homes

Increase recruitment and retention performance and patient diversity of your site mix with a proven solution that delivered over 320+ decentralised trials since 2012

Decentralized Clinical Trials FutureMeds

Hybrid
Solutions

Protect site and PI oversight by conducting some on-site visits and offering patients the option for remote-friendly visits at their chosen location, such as their homes or offices. Available in 18 European countries.

Virtual
Clinical Trials

Conduct all visits remotely, providing ultimate convenience for participants without risking compliance and data quality utilising FutureMeds @home's home nursing and our experienced PIs.

Where to
start?

Our experts can guide your company through the selection process, ensuring the right fit for your study

Arrange a meeting

Optimise your protocol delivery with a proven DCT solution, TA expertise and protocol input

FutureMeds @home's DCT specialists can assist from early protocol development throughout the whole trial journey to boost PI oversight and, ultimately, the performance of your site mix

Tried, tested, optimised

FutureMeds @home is the only European, independent DCT solution with over 12 years of experience that combines deep site business expertise with DCT expertise

1,850+

Non-FutureMeds sites supported

120+

40+

CROs

Supported

12.5k+

Homecare visits delivered

320+

Trials supported across 24+ TAs and 140+ indications

1,350+

Fully vetted homecare providers

Access larger & more diverse populations

Bring your trial directly to the patient's home with FutureMeds @home, our patient-centric DCT solution. It is designed to enhance the convenience and accessibility of trial participation, ensuring broader patient engagement and stronger real-world data. Utilise it at our sites or support your site mix across our 18 DCT countries.

1,350+ trained homecare providers in 18 countries

Increased patient diversity, engagement & retention

Arrange a meeting

Flexible scalability across TAs and protocols

Boost your success rates and protect your last patient in deadlines via FutureMeds @home. This DCT solution, with over 12 years of track record, can efficiently manage large-scale, geographically diverse trials, adapt to various protocols and designs, and work with challenging risk groups, rare diseases and pediatric patients.

Proven solutions for patient population that cannot access conventional studies

320+ trials across 25 TA’s & 140+ indications

Patient Pathways

Boost PI and Site Engagement

Maximise your site mix performance and boost patient experience with FutureMeds @home. Building on a deep understanding of the site model and through our robust SOPs, training, support service and delivery, we can help overcome Pl and site-specific challenges and issues.

1,850+ non-FutureMeds sites supported

Site Engagement Framework to boost DCT adoption in Europe

Discover More

Increase accountability & transparency

Increase your direct oversight & control through FutureMeds @home's single point of contact, qualified country coordinators, local experts and proprietary solutions that eliminate the need for additional sub-vendors and enable full accountability and streamlined communication.